Polls on my Pod: Bengal Flips, Vijay Disrupts, Kerala Resets
May 4, 2026 - 25:40
Radio and PodcastLive Radio & Podcasts
News & Politics
Sun–Organon: The scope, risks, and future of India's biggest pharma deal
India's largest drugmaker, Sun Pharma, has announced the acquisition of US-based Organon in a landmark $11.75 billion all-cash deal, the biggest overseas purchase by an Indian company since Tata-Corus in 2007. The move e...
About This Episode
Sun–Organon: The scope, risks, and future of India's biggest pharma deal is an episode from The Morning Brief by The Economic Times. India's largest drugmaker, Sun Pharma, has announced the acquisition of US-based Organon in a landmark $11....
Podcast
This episode belongs to The Morning Brief.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Apr 30, 2026, 16:42 long, audio available.
Related Episodes
How Guneet Monga Rewrote Bollywood's Rules and Won an Oscar Doing It
May 4, 2026 - 42:39
Guns, Glamour & Girl Bosses
May 3, 2026 - 11:15
AAP’s Breaking Point: The Exit of Seven
May 1, 2026 - 21:18
Polls On My Pod: Fish, Faith & the SIR Fear: Can Mamata Hold Bengal?
Apr 28, 2026 - 29:32
ET Deep Dive: Swipe Left on Reality
Apr 26, 2026 - 10:55
Polls On My Pod: TN and the Thalapathy Factor
Apr 23, 2026 - 12:10
India's Medical Tourism Slips Off the Table
Apr 21, 2026 - 17:09
Questions About This Episode
Where can I listen to Sun–Organon: The scope, risks, and future of India's biggest pharma deal?
You can listen to Sun–Organon: The scope, risks, and future of India's biggest pharma deal online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Sun–Organon: The scope, risks, and future of India's biggest pharma deal from?
Sun–Organon: The scope, risks, and future of India's biggest pharma deal is an episode from The Morning Brief by The Economic Times.
How long is this episode?
This episode is 16:42 long.
When was this episode published?
This episode was published on Apr 30, 2026.